10-Q: TruBridge, Inc. Reports Q1 2025 Results: Revenue Up, Company Reports Material Weakness in Internal Controls
Quarterly Report
TruBridge, Inc. announces a revenue increase and a net income turnaround in Q1 2025, but also discloses a material weakness in internal control over financial reporting.
Summary
- TruBridge, Inc. reported a 4% increase in total revenues for the three months ended March 31, 2025, reaching $87.2 million compared to $84.1 million in the same period of 2024.
- The company achieved a net income of $0.5 million in Q1 2025, a significant improvement from the net loss of $1.9 million in Q1 2024.
- Financial Health revenues increased by 5% to $56.1 million, driven by growth in core RCM services.
- Patient Care revenues increased slightly by 1% to $31.1 million, with growth in installation and SaaS revenue offsetting declines from the sunset of the Centriq product and the divestiture of AHT.
- The company's effective tax rate for the quarter was 90.7%, compared to 42.7% in the prior year, due to an increase in the federal and state valuation allowance on deferred tax assets.
- TruBridge disclosed a material weakness in internal control over financial reporting related to the recording of revenue transactions.
- The company is implementing remediation efforts, including customer contract life cycle management tools and strengthening the finance team.
- As of March 31, 2025, TruBridge had $10.1 million in cash and cash equivalents and $46.6 million in remaining borrowing capacity under its revolving credit facility.
- The company's twelve-month backlog as of March 31, 2025, was approximately $3.3 million for non-recurring system purchases and $327.8 million for recurring payments under support, maintenance, and RCM services.
Sentiment
Score: 6
Explanation: The report shows improved financial performance with increased revenue and a shift to net income. However, the disclosure of a material weakness in internal controls tempers the positive outlook.
Positives
- Total revenues increased by 4% year-over-year.
- The company turned a net loss into a net income.
- Financial Health segment showed strong revenue growth.
- Patient Care segment experienced revenue growth despite headwinds from product sunsets and divestitures.
- The company is actively addressing the material weakness in internal controls with a remediation plan.
Negatives
- A material weakness in internal control over financial reporting was identified.
- The effective tax rate was significantly higher due to valuation allowance adjustments.
- Patient Care revenue growth was partially offset by the sunset of the Centriq product and the divestiture of AHT.
- Financial Health bookings during the first quarter of 2025 decreased by $1.6 million, or 11%, from the first quarter of 2024.
Risks
- The material weakness in internal control over financial reporting could lead to material misstatements in future financial statements.
- High effective tax rate could negatively impact future profitability.
- The company faces risks related to saturation of its target market, regulatory uncertainty, and competition.
- The company's substantial indebtedness could adversely affect its business operations.
- The company's success depends on its ability to cross-sell Financial Health services into its Patient Care customer base.
Future Outlook
The company aims to achieve long-term revenue growth by cross-selling Financial Health services, expanding market share, and pursuing competitive Patient Care opportunities. They also intend to grow through acquisitions. The company expects the trend of customers preferring SaaS license models to continue.
Management Comments
- Management is focused on improving the health of the communities they serve, connecting communities for a better patient care experience, and improving the financial operations of their customers.
- Management believes healthcare IT will be an area of continued investment due to its unique potential to improve safety and efficiency and reduce costs while meeting current and future regulatory, compliance and government reimbursement requirements.
Industry Context
The healthcare industry is facing increasing pressure to reduce costs and increase quality, which is driving adoption of healthcare IT and demand for business management and consulting services. The shift towards value-based reimbursement models is also influencing the industry.
Comparison to Industry Standards
- The company competes with larger firms such as Cerner (now Oracle Health), Epic Systems, and Allscripts in the EHR market, and companies like OptumInsight, Conifer Health Solutions, and R1 RCM in the RCM market.
- The company's focus on rural and community hospitals differentiates it from competitors primarily targeting larger health systems.
- The company's shift towards SaaS models aligns with industry trends, as seen with companies like Veeva Systems and Athenahealth.
- The company's customer retention rate of 94.9% is comparable to industry leaders in the healthcare IT space.
Stakeholder Impact
- Shareholders will likely react positively to the improved financial performance but negatively to the disclosure of a material weakness.
- Employees may be affected by ongoing cost optimization efforts and organizational realignments.
- Customers may benefit from the company's focus on improving patient care and financial operations.
- Creditors will be interested in the company's ability to service its debt and maintain compliance with covenants.
Next Steps
- The company will continue to implement remediation efforts to address the material weakness in internal control over financial reporting.
- The company will continue to integrate policies, processes, people, technology and operations for our combined operations, and will continue to evaluate the impact of any related changes to internal controls over financial reporting during the fiscal year.
- The company will be providing bookings on an Annual Contract Value (ACV) basis in addition to the reported bookings amounts, which has historically represented a mix of ACV and Total Contract Value (TCV) for Patient Care.
Key Dates
| Date | Description |
|---|---|
| January 16, 2024 | Entered into a Stock Purchase Agreement to sell American HealthTech, Inc. |
| March 4, 2024 | Computer Programs and Systems, Inc. changed its corporate name to TruBridge, Inc. |
| March 26, 2024 | Board of directors declared a dividend of one right for each share of common stock. |
| April 4, 2024 | Record date for the dividend of rights. |
| April 22, 2024 | Amendment to the Rights Agreement. |
| May 2024 | Company realigned its reporting structure. |
| February 11, 2025 | Entered into the Second Amendment to the Rights Agreement, terminating the Rights Agreement. |
| February 12, 2025 | Rights Agreement expired. |
| April 9, 2025 | Sold the building and a portion of the land for $0.3 million. |
| May 1, 2025 | There were 15,023,378 shares of the issuer's common stock outstanding. |
| May 9, 2025 | Date these condensed consolidated financial statements were issued. |
Keywords
Financial Health, Patient Care, revenue cycle management, electronic health records, SaaS, internal control, material weakness, TruBridge, bookings, EHR
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.